The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients

Stefania Caria, Adamasco Cupisti, Giovanna Sau, Piergiorgio Bolasco, Stefania Caria, Adamasco Cupisti, Giovanna Sau, Piergiorgio Bolasco

Abstract

Background: Infrequent dialysis, namely once-a-week session combined with very low-protein, low-phosphorus diet supplemented with ketoacids was reported as a useful treatment schedule for ESRD patients with markedly reduced residual renal function but preserved urine output. This study reports our findings from the application of a weekly dialysis schedule plus less severe protein restriction (standard low-protein low-phosphorus diet) in stage 5 CKD patients with consistent dietary discipline.

Methods: This is a multicenter, prospective controlled study, including 68 incident CKD patients followed in a pre-dialysis clinic with Glomerular Filtration Rate 5 to 10 ml/min/1.73/ m2 who became unstable on the only medical treatment. They were offered to begin a Combined Diet Dialysis Program (CDDP) or a standard thrice-a-week hemodialysis (THD): 38 patients joined the CDDP, whereas 30 patients chose THD. Patients were studied at baseline, 6 and 12 months; hospitalization and survival rate were followed-up for 24 months.

Results: Volume output and residual renal function were maintained in the CDDP Group while those features dropped quickly in THD Group. Throughout the study, CDDP patients had a lower erythropoietin resistance index, lower β2 microglobulin levels and lower need for cinacalcet of phosphate binders than THD, and stable parameters of nutritional status. At 24 month follow-up, 39.4% of patients were still on CDDP; survival rates were 94.7% and 86.8% for CDDP and THD patients, respectively, but hospitalization rate was much higher in THD than in CDDP patients. The cost per patient per year resulted significantly lower in CDDP than in THD Group.

Conclusions: This study shows that a CDDP served to protect the residual renal function, to maintain urine volume output and to preserve a good nutritional status. CDDP also blunted the rapid β2 microglobulin increase and resulted in better control of anemia and calcium-phosphate abnormalities. CDDP was also associated with a lower hospitalization rate and reduced need of erythropoietin, as well as of drugs used for treatment of calcium-phosphate abnormalities, thus leading to a significant cost-saving. We concluded that in selected ESRD patients with preserved urine output attitude to protein restriction, CDDP may be a beneficial choice for an incremental hemodialysis program.

Figures

Figure 1
Figure 1
Changes in urine volume (a), serum albumin (b), β2-microglobulin (c) and serum phosphorus (d) in CDDP Group (dotted Line) and THD Group (full line), at baseline, 6 and 12 months of follow-up.
Figure 2
Figure 2
Cumulative survival in CDDP group (Dotted line) and in THD Group (Full line).

References

    1. US Renal Data System . USRDS 2006 Annual Data Repost: Atlas of End-Stage Renal Disease in the United States. Bethesda MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease; 2007.
    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047. doi: 10.1001/jama.298.17.2038.
    1. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;18:1047–1052. doi: 10.1136/.
    1. De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker and a new target for therapy. Kidney Int Suppl. 2005;98:S25–S29. doi: 10.1111/j.1523-1755.2005.09805.x.
    1. Mitch WE, Sapir DG. Evaluation of reduced dialysis frequency using nutritional therapy. Kidney Int. 1981;20:122–126. doi: 10.1038/ki.1981.113.
    1. Morelli E, Baldi R, Barsotti G, Ciardella F, Cupisti A, Dani L, Mantovanelli A, Giovannetti S. Combined therapy for selected chronic uremic patients: infrequent hemodialysis and nutritional management. Nephron. 1987;47:161–166. doi: 10.1159/000184484.
    1. Locatelli F, Andrulli S, Pontoriero G, Di Filippo S, Bigi MC. Supplemented low- protein diet and once weekly hemodialysis. Am J Kidney Dis. 1994;24:192–204. doi: 10.1016/S0272-6386(12)80181-8.
    1. Cardelli R, D’Amicone M, Manzione A, Gurioli L, Grotti G, Biselli L, Priasca G, Agagliati D. Weekly dialysis combined with low-protein diet and essential amino acids. Preliminary data. Minerva Urol Nefrol. 1991;43:211–216.
    1. Brauer JH, Brooks CS, Burch RN. Renal function studies in man with advanced renal insufficiency. Am J Kidney Dis. 1982;2:30–35. doi: 10.1016/S0272-6386(82)80040-1.
    1. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16:459–466. doi: 10.1681/ASN.2004060447.
    1. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985;27:58–65. doi: 10.1038/ki.1985.10.
    1. Daugirdas J. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205–1213.
    1. Locatelli F, Andrulli S, Memoli B, Maffei C, Del Vecchio L, Aterini S, De Simone W, Mandalari A, Brunori G, Amato M, Cianciaruso B, Zoccali C. Nutritional-inflammation status and resistance to erythropoietin therapy in hemodialysis patients. Nephrol Dial Transpl. 2006;21:991–998. doi: 10.1093/ndt/gfk011.
    1. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–1251. doi: 10.1016/0895-4356(94)90129-5.
    1. Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013;33:180–190. doi: 10.1016/j.semnephrol.2012.12.018.
    1. D’Alessandro C, Rossi A, Innocenti M, Ricchiuti G, Bozzoli L, Sbragia G, Meola M, Cupisti A. Dietary protein restriction for renal patients: don’t forget protein-free foods. J Ren Nutr. 2013;23:367–371. doi: 10.1053/j.jrn.2012.12.006.
    1. Levin A, Djurdjiev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52:661–671. doi: 10.1053/j.ajkd.2008.06.023.
    1. Sciffl H, Lang SM, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001;16:1863–1869. doi: 10.1093/ndt/16.9.1863.
    1. Schouten WE, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nube MJ. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant. 2000;15:379–384. doi: 10.1093/ndt/15.3.379.
    1. Maduell F, Navarro V, Cruz MC, Torregrosa E, Garcia D, Simon V, Ferrero JA. Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis. 2002;40:582–589. doi: 10.1053/ajkd.2002.34918.
    1. Vanholder R, Glorieux G, Van Biesen W. Advantages of new hemodialysis membranes and equipment. Nephron Clin Pract. 2010;114:c165–c172. doi: 10.1159/000262298.
    1. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kessehut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA, for the IDEAL Study A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363:606–619. doi: 10.1056/NEJMoa1000552.
    1. Di Iorio BR, Minutolo R, De Nicola L, Bellizzi V, Catapano F, Iodice C, Rubino R, Conte G. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney Int. 2003;64:1822–1828. doi: 10.1046/j.1523-1755.2003.00282.x.
    1. Stenvinkel P, Bàràny P. Anemia, rHuEPO resistance and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress. Nephrol Dial Transplant. 2002;17(Suppl 5):S32–S37. doi: 10.1093/ndt/17.suppl_5.32.
    1. Filipowicz R, Beddhu S. Optimal nutrition for predialysis chronic kidney disease. Adv Chronic Kidney Dis. 2013;20:175–180. doi: 10.1053/j.ackd.2012.12.007.
    1. Fouque D, Wamg P, Laville M, Boissel JP. Low protein diets delay end-stage renal disease in non diabetic adults with chronic renal failure. Nephrol Dial Transplant. 2000;15:1986–1992. doi: 10.1093/ndt/15.12.1986.
    1. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant. 2011;26:1608–1614. doi: 10.1093/ndt/gfq630.
    1. Da Silva-Gane M, Wellsted D, Greenshields H, Norton S, Chandna SM, Farrington K. Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol. 2012;7:2002–2009. doi: 10.2215/CJN.01130112.
    1. Brunori G. Treatment of chronic kidney disease in the elderly: diet or conservative management. J Nephrol. 2012;25(Suppl 19):S28–S31. doi: 10.5301/jn.5000143.
    1. I National Kidney Foundation – K/DOQI: update 2000Am J Kidney Dis 2001,37(Suppl 1):S7--S64.31.
    1. Kalantar-Zadeh K, Casino FG. Let us give twice-weekly hemodialysis a chance: revisiting the taboo. Nephrol Dial Transplant. 2014;29(9):1618–1620. doi: 10.1093/ndt/gfu096.
    1. European best practice guidelines expert group on haemodialysisNephrol Dial Transplant 2002,17(Suppl 7):S16-S31.
    1. Rhee CM, Unruh M, Chen J, Kovesdy CP, Zage P, Kalantar-Zadeh K. Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial. 2013;26:720–727. doi: 10.1111/sdi.12133.
    1. Cupisti A, D’ Alessandro C, Morelli E, Manca Rizza G, Galetta F, Franzoni F, Barsotti G. Nutritional status and dietary manipulation in predialysis chronic renal failure patients. J Ren Nutr. 2004;14:127–133. doi: 10.1053/j.jrn.2004.04.002.
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel